Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates.
Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium.
For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register.
For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.

Patent details

3762026 Title: UTILISATION D'INHIBITEUR DE PCSK9 POUR RÉDUIRE LE RISQUE CARDIOVASCULAIRE

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic information

Application number:
197152804
WO application number:
US2019021034
Type:
European patent granted for BE
Status:
Open
Publication number:
3762026
WO publication number:
WO2019173530
1rst applicant's nationality:
Translation language:
EPO publication language:
English
SPC number:

Dates

Filing date:
06/03/2019
Grant date:
08/04/2026
EP publication date:
13/01/2021
WO publication date:
12/09/2019
Claims translation received date:
Translation received date (EP publication B1):
Translation received date (EP publication B2):
Translation received date (EP publication B3):
Registration date:
08/04/2026
EP B1 publication date:
08/04/2026
EP B2 publication date:
EP B3 publication date:
Lapsed date:
Expiration date (if granted and all annual fees paid):
06/03/2039

Applicant

1

Name:
Sanofi Biotechnology
Legal Form:
From:
08/04/2026
Address:
82 Avenue Raspail, 94250 Gentilly, France (FR)
To:

2

Name:
Regeneron Pharmaceuticals, Inc.
Legal Form:
From:
08/04/2026
Address:
777 Old Saw Mill River Road, Tarrytown, NY 10591, United States (US)
To:

Inventor

1

Name:
SCHWARTZ, Gregory
Legal Form:
Address:
Denver, Colorado 80220, United States (US)

2

Name:
PORDY, Robert
Legal Form:
Address:
New York 10591, United States (US)

3

Name:
BESSAC, Laurence
Legal Form:
Address:
75008 Paris, France (FR)

4

Name:
HANOTIN, Corinne
Legal Form:
Address:
75008 Paris, France (FR)

5

Name:
SASIELA, William
Legal Form:
Address:
New York 10591, United States (US)

6

Name:
STEG, Philippe
Legal Form:
Address:
75008 Paris, France (FR)

Priority

1

Priority patent number:
201962806313 P
Priority date:
15/02/2019
Priority country:
United States (US)

2

Priority patent number:
201962802545 P
Priority date:
07/02/2019
Priority country:
United States (US)

3

Priority patent number:
201962797680 P
Priority date:
28/01/2019
Priority country:
United States (US)

4

Priority patent number:
201862775219 P
Priority date:
04/12/2018
Priority country:
United States (US)

5

Priority patent number:
201862770530 P
Priority date:
21/11/2018
Priority country:
United States (US)

6

Priority patent number:
201862746319 P
Priority date:
16/10/2018
Priority country:
United States (US)

7

Priority patent number:
201862744008 P
Priority date:
10/10/2018
Priority country:
United States (US)

8

Priority patent number:
201862736284 P
Priority date:
25/09/2018
Priority country:
United States (US)

9

Priority patent number:
201862717530 P
Priority date:
10/08/2018
Priority country:
United States (US)

10

Priority patent number:
201862688622 P
Priority date:
22/06/2018
Priority country:
United States (US)

11

Priority patent number:
201862683695 P
Priority date:
12/06/2018
Priority country:
United States (US)

12

Priority patent number:
201862657495 P
Priority date:
13/04/2018
Priority country:
United States (US)

13

Priority patent number:
201862641918 P
Priority date:
12/03/2018
Priority country:
United States (US)

14

Priority patent number:
201862641082 P
Priority date:
09/03/2018
Priority country:
United States (US)

15

Priority patent number:
201862640361 P
Priority date:
08/03/2018
Priority country:
United States (US)

16

Priority patent number:
201862639407 P
Priority date:
06/03/2018
Priority country:
United States (US)

17

Priority patent number:
19305247
Priority date:
04/03/2019
Priority country:
European Patent Office (EPO) (EP)

Classification

IPC or IDT classification:
C07K 16/40; A61K 39/00; G01N 33/92; A61P 9/00;

Publication

European Patent Bulletin

Issue number:
202615
Publication date:
08/04/2026
Description:
Grant (B1)

Annual fee

Annual fee(s) Due Date:
31/03/2027
Annual fee number:
9
Annual fee amount:
165 Euro
Expected payer:
Last annual fee payment date:
Last annual fee paid number:
Payer:
Filing date Document type Publication Type Document Description Number of pages File Type